96228 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
#302S1P receptors modulators and their use thereof
#303Phosphorus derivatives as kinase inhibitors
#304Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
#305Bone targeted therapeutics and methods of making and using the same
#306Directed synthesis of oligophosphoramidate stereoisomers
#307Hepatitis C inhibitors and uses thereof
#308Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
#309Triazacyclononane-based phosphinate ligand and its use for molecular imaging
#310Indole compounds as an inhibitor of cellular necrosis
#311Compound, novel ligand, novel transition metal complex, and catalyst including novel transition metal complex
#312Uridine di- or tri-phosphate derivatives and uses thereof
#313Carboxy X rhodamine analogs
#314Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition
#315Aminopyrimidine kinase inhibitors
#316Inhibitors of flaviviridae viruses
#317Gyrase and topoisomerase IV inhibitors
#318Methods of preparing substituted nucleotide analogs
#319Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
#320Phosphonic acid compounds as inhibitors of serine proteases
#321Methods of preparing substituted nucleotide analogs
#322Indole and indazole compounds as an inhibitor of cellular necrosis
#323Bone-targeting bisphosphonate duplex drugs
#324Phosphorus Derivatives as Kinase Inhibitors
#325Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
#326Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#327MODULAR CONSTRUCTION OF LIPOPHOSPHOLIPIDS
#328Benzopyran compounds, compositions and uses thereof
#329Nucleoside phosphoramidates
#330Compounds as receptor modulators with therapeutic utility
#331Phosphate esters of gyrase and topoisomerase inhibitors
#332Methods for the synthesis and purification of oligomers
#333Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same
#334FRET-BASED ZINC(II) ION INDICATOR
#335BICYCLO[6.1.0]NON-4-YNE REGENTS FOR CHEMICAL MODIFICATION OF OLIGONUCLEOTIDES
#336Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
#337Monomers and oligonucleotides comprising cycloaddition adduct(s)
#338Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity
#339GLYCOSIDE DERIVATIVES AND USES THEREOF
#340Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-YL]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
#341Tubulin polymerisation inhibitors
#342Morpholino-based antisense agent
#343Phosphate-containing nanoparticle delivery vehicle
#344Phosphonic acid compounds as inhibitors of serine proteases
#345Phosphate-containing nanoparticle delivery vehicle
#346Glycoside derivatives and uses thereof
#347PROCESS FOR SYNTHESIZING PHOSPHONIC AND PHOSPHINIC ACID COMPOUNDS
#348Indole compounds as an inhibitor of cellular necrosis
#349Salts of prodrugs of piperazine and substituted piperidine antiviral agents
#350Phosphonic acid compounds as inhibitors of serine proteases
#351Synthesis of phosphoric esters
#352Phosphorous derivatives as kinase inhibitors
#353Phosphorus containing quinazoline compounds and methods of use
#354Gyrase and topoisomerase IV inhibitors
#355Cold menthol receptor-1 antagonists
#356Composition and Methods of Treating Viral Infections and Viral Induced Tumors
#357Inhibitors of viruses
#358Phosphonate fluorescent dyes and conjugates
#3592'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
#360QUINOLINES AS INHIBITORS OF FARNESYL PYROPHOSPHATE SYNTHASE
#361Compounds for fluorescent labeling
#362Cold menthol receptor-1 antagonists
#363Compounds for the treatment of proliferative disorders
#364Phosphonic acid compounds as inhibitors of serine proteases
#365S1P receptors modulators and their use thereof
#366Potent chimeric NRTI-NNRTI bifunctional inhibitors of HIV-1 reverse transcriptase
#3674-AMINOQUINAZOLINE PRODRUGS
#368Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
#369Activators of glucokinase
#370Reagent compounds and methods of making same
#371Compounds and pharmaceutical compositions for the treatment of viral infections
#372AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY
#373Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1′-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
#374Stereoselective synthesis of phosphorus containing actives
#375Inhibitors of matrix metalloproteinases
#376Compounds as receptor modulators with therapeutic utility
#377Directed synthesis of oligophosphoramidate stereoisomers
#378Triazole compounds that modulate HSP90 activity
#379Modulation of HIF1α and HIF2α expression
#380Macrocyclic Prodrug Compounds Useful as Therapeutics
#381Protective group for synthesis of RNA and derivative
#382Photocleavable Linker Methods and Compositions
#383Compounds as receptor modulators with therapeutic utility
#384Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
#385Heterocycle-substituted xanthene dyes
#386RNAi Agents Comprising Universal Nucleobases
#387Phosphonic acid compounds as inhibitors of serine proteases
#388Phosphonic acid compounds as inhibitors of serine proteases
#389Phosphonic acid compounds as inhibitors of serine proteases
#390Nucleoside Phosphonate Analogs
#391Xanthene dyes
#392NOVEL SULFONAMIDOMETHYLPHOSPHONATE INHIBITORS OF BETA-LACTAMASE
#393Azolylmethyloxiranes, use Thereof and Agents Containing the Same
#394Nucleoside phosphoramidates
#395ANTIVIRAL COMPOUNDS
#396Tubulin polymerisation inhibitors
#397INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
#398Pharmacologically active agents containing esterified phosphonates and methods for use thereof
#399Phosphonate fluorescent dyes and conjugates
#400Inhibitors of janus kinases
#401Phosphothiophene and phosphothiazole HCV polymerase inhibitors
#402Indole compounds as an inhibitor of cellular necrosis
#403Prodrugs of piperazine and substituted piperidine antiviral agents
#404Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
#405Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
#406Indole and indazole compounds as an inhibitor of cellular necrosis
#407Convertible nucleoside derivatives
#408REACTIONS OF GROUP 16 ELEMENTS
#409Amine compound and pharmaceutical use thereof
#4105' O [(N ACYL)AMIDOPHOSPHATE] AND 5' O [(N ACYL)AMIDOTHIOPHOSPHATE] AND 5' O [(N ACYL)AMIDODITHIOPHOSPHATE] AND 5' O [(N ACYL)AMIDOSELENOPHOSPHATE] DERIVATIVES OF NUCLEOSIDES AND PROCESSES FOR THE MANUFACTURE THEREOF
#411Insecticidal substituted amino heterocyclic and heteroaryl derivatives
#412Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis
#413Nucleoside analogs for antiviral treatment
#414Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction
#415Photocleavable linker methods and compositions
#416Thiophene compound having phosphoric ester and process for producing the same
#417ANTIVIRAL PROTEASE INHIBITORS
#418Oligonucleotides comprising a modified or non-natural nucleobase
#419Compounds for the treatment of proliferative disorders
#420Phosphorus derivatives as histone deacetylase inhibitors
#4216,11-bridged biaryl macrolides
#422BCRP/ABCG2 inhibitor
#423ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS
#424Assay methods using chemiluminescent detection of peroxidase
#425Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections
#426Bone targeted therapeutics and methods of making and using the same
#427ALDH-2 inhibitors in the treatment of addiction
#428Compounds and pharmaceutical compositions for the treatment of viral infections
#429Phospho-indoles as HIV inhibitors
#430Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
#431PHOSPHONATE ANALOGS OF ANTIMETABOLITES
#432Substituted Phosphate Esters of Nucleoside Phosphonates
#433Phosphonic acid compounds as inhibitors of serine proteases
#434Novel phosphonic acid compounds as inhibitors of serine proteases
#435Novel phosphonic acid compounds as inhibitors of serine proteases
#436BIPHENYLAZETIDINONE CHOLESTEROL ABSORPTION INHIBITORS
#437Phosphonic acid compounds as inhibitors of serine proteases
#438Process for synthesizing phosphonic and phosphinic acid compounds
#439Novel phosphonic acid compounds as inhibitors of serine proteases
#440Phosphonic acid compounds as inhibitors of serine proteases
#441Novel phosphonic acid compounds as inhibitors of serine proteases
#442Phosphonic acid compounds as inhibitors of serine proteases
#443Novel phosphonic acid compounds as inhibitors of serine proteases
#444Antiviral protease inhibitors
#445DIOXOLANE THYMINE PHOSPHORAMIDATES AS ANTI-HIV AGENTS
#446Amide-substituted xanthene dyes
#447Activators for oligonucleotide synthesis
#448Therapeutic substituted piperidone compounds
#449Novel inhibitors of chymase
#450Trityl Derivatives for Enhancing Mass Spectrometry
#451Pesticidal heterocycles
#452Inhibitors of matrix metallaproteinases
#453Synthesis of drug conjugates via reaction with epoxide-containing linkers
#454MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH
#455Facilitated transport of bisphosphonates by vitamin C
#456Lipid analogs for combating tumors
#457Phosphoramidate derivatives of FAU
#458Agent for preventing or treating neuropathy
#459COLD MENTHOL RECEPTOR-1 ANTAGONISTS
#460Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections
#461Compounds and pharmaceutical compositions for the treatment of viral infections
#462Compounds and pharmaceutical compositions for the treatment of liver disorders
#463Oligonucleotide probe
#464XANTHENE DYES
#465RNAi Agents Comprising Universal Nucleobases
#466PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES
#467ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION
#468Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof
#469Phosphonate Derivatives of Mycophenolic Acid
#470ANTI-INFECTIVE PHOSPHONATE ANALOGS
#471Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia
#472Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase
#4732-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases
#474Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity
#4753′-end nucleoside unit comprising phosphoramidite
#476Therapeutic compounds
#477ALDH-2 INHIBITORS IN THE TREATMENT OF DRUG ADDICTION
#478Cold menthol receptor-1 antagonists
#479Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#480N3 alkylated benzimidazole derivatives as MEK inhibitors
#481Inhibitors of β-lactamase
#482Transition state structure and inhibitors of thymidine phosphorylases
#483Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#484Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase
#4852′-fluoronucleoside phosphonates as antiviral agents
#486Seven-membered ring nucleosides
#487Compounds for the treatment of proliferative disorders
#488Phosphonate fluorescent dyes and conjugates
#489Macrocyclic oligonucleotide labeling reactants and conjugates derived thereof
#490Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
#491Inorganic boranophosphate salts
#492Lipid analogs for inhibiting HIV-1 activity
#493Lipid analogs for inhibiting the activity of hepatitis B antigen
#494Lipid analogs for combating tumors
#495Coumarin-based amino acids for use in enzyme activity and substrate specificity assays
#496Therapeutic phosphonate derivatives
#497Phosphonate analogs of antimetabolites
#498Modulation of HIF1alpha and HIF2alpha expression
#499Compositions and methods for enhanced delivery to target sites
#500Aryl Phosphate Derivatives of d4T
#5014-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching
#502Mono-lysine salts of azole compounds
#503Therapeutic phosphonate compounds
#504RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
#505Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
#506Antisense modulation of farnesoid X receptor expression
#507Pyridinium-betain compounds and their use
#508Phosphonylated fluorescent dyes and conjugates
#509Anti-inflammatory phosphonate compounds
#510Process and methods for the preparation of optically active cis-2-hydroxymethyl-4- (cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
#511Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens
#512Difluoronucleosides and process for preparation thereof
#513Building block capable of transferring a functional entity
#514System for delivering therapeutic agents into living cells and cells nuclei
#515Azole derivatives and methods for making the same
#516Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
#517Prodrugs of mitotic kinesin inhibitors
#518Novel inhibitors of beta-lactamase
#519Phospho-indoles as HIV inhibitors
#520Quinazoline compounds
#521Method for producing dialdehydes and or ethylenically unsaturated monoaldehydes by hydroformylating ethylenically unsaturated compounds
#522Cytotoxic nucleoside analog compound 003 for treating cancer
#523Activators for oligonucleotide synthesis
#524Noncardiotoxic pharmaceutical compounds
#525Oligonucleotides comprising a modified or non-natural nucleobase
#526Heteroaryl substituted benzothiazole dioxetanes
#527Agent for preventing or treating neuropathy
#528Compounds, compositions and methods for treating or preventing viral infections and associated diseases
#529Aryl phosphate derivatives of d4T
#530Nucleoside phosphonate analogs
#531Phosphonic diester derivatives
#532Dioxolane analogs for improved inter-cellular delivery
#533Amino phosphonate and amino bis-phosphonate derivatives
#534Heterocyclic compounds and their use in the detection of nucleic acids
#535Anti-infective phosphonate analogs
#536Prodrugs of piperazine and substituted piperidine antiviral agents
#537RNA interference mediated inhibition of checkpoint Kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
#538Pharmacologically active agents containing esterified phosphonates and methods for use thereof
#539Building block capable of functional entity transfer to nucleophil
#540Inhibitors of chymase
#541Aryl fructose-1,6-bisphosphatase inhibitors
#542Xanthene dyes
#543Assay methods using chemiluminescent detection of peroxidase
#544Pesticidal heterocycles
#545Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels
#546Organophosphorus derivatives of indazoles and use thereof as medicinal products
#547Novel chelating agents and chelates and their use
#548Lipid analogs for treating viral infections
#549Azole or triazole derivatives, method for preparing same and use thereof as fungicides
#550Inhibitors of β-lactamase
#551Edg receptor agonists
#552N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists
#553Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate